Kiran Mazumdar-Shaw urges India to achieve ‘biotech sovereignty’ by 2047, driven by a $330 bn bioeconomy, BioE3 framework, scale exports, a sovereign AI stack, and crucial R&D investment
Read Full
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
